uniQure N.V — 四半期キャッシュフロー (NASDAQ:QURE) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 556.54 M605.4 M584.89 M888.38 M824.91 M 負債合計 563.29 M571.72 M588.89 M659.64 M626.01 M 純資産合計 -6.75 M33.69 M-4 M228.75 M198.9 M 負債および純資産合計 556.54 M605.4 M584.89 M888.38 M824.91 M 有利子負債合計 51.32 M51.59 M51.84 M51.88 M49.7 M 純負債 -316.36 M-357.43 M-325.3 M-642.42 M-573.15 M

uniQure N.V

uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.

ニュース

Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?

uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims - TipRanks.com

Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They?

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

A Unique Situation For UniQure (QURE)

FDAの指導部交代を受けてMizuhoがuniQure株の格付けを引き上げ

Mizuho upgrades uniQure stock rating on FDA leadership change

Avago, Lumentum among market cap stock movers on Monday

Chardan、FDA指導部交代を受けてuniQure株の目標株価を引き上げ

Chardan raises uniQure stock price target on FDA leadership change

Tesla and Facebook among market cap stock movers on Monday

Biotech Stocks Pop After CBER Chief Exit - Moderna (NASDAQ:MRNA)